A Letter From Porter Stansberry
On this dedicated website, Porter shows you how to capitalize on a historic convergence of three powerful forces... one that’s never happened before in human history.
Welcome to Porter & Co. Biotechnology… the only place to ride the next bull market in biotech to life-changing wealth.
When Porter & Co. launched this advisory in 2024, we delivered incredible gains in a bear market: Sagimet Biosciences (SGMT), up 217%, uniQure (QURE), up 237%, and aTyr Pharmaceutical (ATYR), up 63%, ... to name a few. In fact, 22 of our 27 biotech picks have positive returns – an 81% win rate.
And now, the massive compute power behind the giant AI build-out is going to supercharge drug discovery – leading to life-changing cures in what Porter calls the “11 Kingdoms Of Medicine.”
Porter’s barbell-portfolio approach balances the highly volatile drug-discovery companies with those steady suppliers of the drug infrastructure – ultimately leading to 30% returns on your investments.What Members Are Saying
Bought 400 shares in April and another 100in June and I am up $2735. That is 123%
I'm up 89% @ $4481.21 gained so far. Thank you!!!! I wish I had joined sooner.
I'm up almost 100% on my SGMT investment. Wish I had put more into it but grateful to you for the great work.
As of last market close I’ve made $15,412.64. Got in at $2.15. Thanks!!!
I'm 100% into ALL of your recommended trades and delighted in the results. Keep it up.
Today, account total is in the green $3,469.86 (+ 203.64 + 298.59 closed) = $3,972.09. I'm thrilled.
A Once-In-A-Generation Moment For Biotech Investors
“It's unlike anything the world has seen before; unless you’re on the ground you really can’t wrap your head around what’s happening. We’re at a tipping point in all these technologies and we’re seeing changes that were unimaginable just a few years ago.”
Porter’s three decades of experiences and connections provide powerful pattern recognition of the green flags and red flags that often presage success or failure for tech companies. And today, he says, is a watershed moment for tech investors. Right now, we are living amid three historic tsunamis gathering force at the same time.
The Popularization of Artificial Intelligence
This tsunami will change our lives in many ways, but most importantly in how we work.
The Mass Adoption of Blockchain and Cryptocurrency
This second tsunami will fundamentally reshape the nature of money and how we transact.
The Revolution Unfolding in Life Sciences
This third tsunami will change how we approach health and disease.
In Porter & Co. Biotechnology, Porter covers all three of these tsunamis, as well as other technological waves changing how we live. He also explores how recent shifts in the outlook for interest rates, inflation, and growth move both markets and stocks – why they matter to technology stocks especially – and how you can take advantage of those moves.
Porter follows a proven, seven-part formula that’s led readers to multiple triple-digit gains. He looks for:
- The Big Picture
- The Opportunity
- The Catalysts
- The Capitalization Table
- The Risk/Reward
In Porter & Co. Biotechnology, our aim is not only to deliver the best coverage of the key trends and the companies behind them, but more importantly to help you make the cash register ring along the way.
35
Total Positions
+26.2%
Avg. Return
71%
Win Rate
9
50%+ Gainers
Top Performers
QURE (2)
uniQure (2nd)
+237.0%
S&P Over Same Period: +6.0%
Biotech
QURE
uniQure
+131.1%
S&P Over Same Period: +28.4%
Biotech
ROIV
Roivant Sciences
+126.9%
S&P Over Same Period: +37.4%
Biotech
SGMT (2)
Sagimet Biosciences (2nd tranche)
+106.4%
S&P Over Same Period: +26.2%
Biotech
TGTX
TG Therapeutics
+97.8%
S&P Over Same Period: +25.8%
Biotech
KOD
Kodiak Sciences
+87.8%
S&P Over Same Period: +8.6%
Biotech
SGMT
Sagimet Biosciences
+71.6%
S&P Over Same Period: +47.3%
Biotech
PRME
Prime Medicine
+60.6%
S&P Over Same Period: +10.4%
Biotech
Crushing The S&P
Porter & Co. Biotechnology recommendations have outperformed the S&P by over 100% and has beat out XBI (a biotech index) by more than 50%.
★ ★ ★ ★ ★
Quick note to state that I have been following Porter's recommendations and am up almost 50K in realized gains
★ ★ ★ ★ ★
Porter is outstanding…. data review, insights, connections added to his experience, analysis, and reasoning are impressive… his picks have made me many $1000’s.. Thanks!
★ ★ ★ ★ ★
Thank you, I’m up 196% and have made over $85,000 in the last two months on Sagimet alone. I buy all of Erez‘s recommendations and am very pleased with the work he does and recommendations he makes. Thank you for your good work.
★ ★ ★ ★ ★
I really appreciative Porter’s analysis. SGMT has been terrific. Tried to buy 100,000 shares when he pounded the table, and it was selling at about half its cash value. Unfortunately, only got 48,300 shares at an average price of 2.93 before it ran above 3. I decided not to chase it further. Too bad. Sold 1/3 of holdings at 8.36 and am holding the rest. Thanks very much.
★ ★ ★ ★
I opened a position in SGMT on 5/12/25 shortly after listening to your black label podcast on Biotech. My entry price was $3.27 per share at 1000 shares. It is currently up appx 150% in less than 2 months. It's been very exciting to have this position and see its price increase so quickly and dramatically. Thank you for the timely insights!
★ ★ ★ ★ ★
All I can say is THANK YOU, THANK YOU!!
★ ★ ★ ★
I am up 97% on my position - Porter is the man!
★ ★ ★ ★ ★
I clearly did not buy enough of sgmt, but I am up 250%!!! I love reading your work and have learned much.
★ ★ ★ ★
I bought SGMT at $2.58; I think in April when I changed from Distressed to Bio. It's now at $8.25. Great!!!!!
★ ★ ★ ★ ★
Up 146% since 2/23/2024. Did dollar cost averaging when price dropped last year. SMR is up 220%. Had I bought it a $2.50 last year would be up 1500%.
★ ★ ★ ★
I followed Porter's advice and invested 10K 6 months ago and it is up 194% for me or $19,461.95. Big winner.